Medistim — Earnings Release 2017

Apr 26, 2017

Results from the 1st quarter 2017 for Medistim ASA

Results from the 1st quarter 2017 for Medistim ASA

Sales for the quarter ended at MNOK 74.4 (MNOK 65.5), an

increase of 13.5 %. Currency neutral growth of own products

was 20.3 %. Operating profit (EBIT) ended at MNOK 16.0 (MNOK

13.5), up 18.4 %. Sales from the US continues to grow and

increased with 9.6 % in USD. Medistim established a sales

organization through a new subsidiary in Spain during the

first quarter. The General Meeting decided to pay a

dividend of NOK 1.75 per share.